Leo Luznik

5.0k total citations
60 papers, 1.8k citations indexed

About

Leo Luznik is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Leo Luznik has authored 60 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 30 papers in Immunology and 23 papers in Oncology. Recurrent topics in Leo Luznik's work include Hematopoietic Stem Cell Transplantation (33 papers), Immune Cell Function and Interaction (19 papers) and Acute Myeloid Leukemia Research (14 papers). Leo Luznik is often cited by papers focused on Hematopoietic Stem Cell Transplantation (33 papers), Immune Cell Function and Interaction (19 papers) and Acute Myeloid Leukemia Research (14 papers). Leo Luznik collaborates with scholars based in United States, United Kingdom and Australia. Leo Luznik's co-authors include Ephraim J. Fuchs, Robert Iannone, Laura Engstrom, Christopher G. Kanakry, Sanju Jalla, Richard J. Jones, Ivan Borrello, Carol Ann Huff, Richard F. Ambinder and Javier Bolaños‐Meade and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Leo Luznik

58 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leo Luznik United States	22	1.3k	910	658	260	237	60	1.8k
Christopher G. Kanakry United States	20	1.6k 1.3×	1.0k 1.1×	588 0.9×	385 1.5×	198 0.8×	70	2.1k
Robert Lowsky United States	20	1.0k 0.8×	1.0k 1.1×	434 0.7×	191 0.7×	167 0.7×	91	1.9k
Brian C. Betts United States	21	578 0.5×	614 0.7×	390 0.6×	84 0.3×	196 0.8×	68	1.2k
RA Nash United States	17	948 0.7×	521 0.6×	272 0.4×	151 0.6×	130 0.5×	33	1.4k
J. C. W. Marsh United Kingdom	16	984 0.8×	374 0.4×	349 0.5×	92 0.4×	165 0.7×	26	1.3k
André Willasch Germany	25	998 0.8×	459 0.5×	448 0.7×	562 2.2×	281 1.2×	66	1.8k
Yani S. Brinson United States	11	1.4k 1.1×	1.4k 1.6×	328 0.5×	76 0.3×	224 0.9×	12	2.0k
Jacopo Mariotti Italy	20	562 0.4×	667 0.7×	410 0.6×	93 0.4×	158 0.7×	56	1.2k
Rosanna Scimè Italy	18	747 0.6×	363 0.4×	403 0.6×	99 0.4×	123 0.5×	51	1.2k
Hildegard Greinix Austria	14	457 0.4×	297 0.3×	427 0.6×	110 0.4×	265 1.1×	41	1.1k

Countries citing papers authored by Leo Luznik

Since Specialization

Citations

This map shows the geographic impact of Leo Luznik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Luznik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Luznik more than expected).

Fields of papers citing papers by Leo Luznik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo Luznik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Luznik. The network helps show where Leo Luznik may publish in the future.

Co-authorship network of co-authors of Leo Luznik

This figure shows the co-authorship network connecting the top 25 collaborators of Leo Luznik. A scholar is included among the top collaborators of Leo Luznik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo Luznik. Leo Luznik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pidala, Joseph A., Ted Gooley, Leo Luznik, & Bruce R. Blazar. (2024). Chronic graft-versus-host disease: unresolved complication or ancient history?. Blood. 144(13). 1363–1373. 12 indexed citations

DeZern, Amy E., Marianna Zahurak, Heather J. Symons, et al.. (2023). Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia. Blood. 141(25). 3031–3038. 18 indexed citations

Koldobskiy, Michael A., Michael I. Barbato, Leo Luznik, et al.. (2022). Donor T cell DNMT3a regulates alloreactivity in mouse models of hematopoietic stem cell transplantation. Journal of Clinical Investigation. 132(13). 13 indexed citations

Fuchs, Ephraim J., Leo Luznik, Javier Bolaños‐Meade, et al.. (2022). Hyperinflammatory syndrome resembling haemophagocytic lymphohistiocytosis following axicabtagene ciloleucel and brexucabtagene autoleucel. British Journal of Haematology. 199(5). 720–727. 13 indexed citations

Buxbaum, Nataliya P., Gèrard Socié, Geoffrey R. Hill, et al.. (2022). Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD. Blood Advances. 7(17). 4886–4902. 11 indexed citations

Hughes, Michael S., Ravi Varadhan, Richard F. Ambinder, et al.. (2022). Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: A single-center experience.. Journal of Clinical Oncology. 40(16_suppl). e19045–e19045. 1 indexed citations

Zahurak, Marianna, Maria Bettinotti, Syed Abbas Ali, et al.. (2021). Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide. Transplantation and Cellular Therapy. 27(11). 909.e1–909.e6. 10 indexed citations

Tschernia, Nicholas, Vaibhav Kumar, Dominic T. Moore, et al.. (2021). Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia. Transplantation and Cellular Therapy. 27(12). 1021.e1–1021.e5. 17 indexed citations

DeZern, Amy E., Hany Elmariah, Marianna Zahurak, et al.. (2020). Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation Cyclophosphamide. Biology of Blood and Marrow Transplantation. 26(11). 2075–2081. 22 indexed citations

10.

Radojčić, Vedran & Leo Luznik. (2020). PTCy and “The Story of the Three Bears”. Bone Marrow Transplantation. 56(4). 765–766. 2 indexed citations

11.

Gojo, Ivana, Robert K. Stuart, Jonathan Webster, et al.. (2019). Multi-Center Phase 2 Study of Pembroluzimab (Pembro) and Azacitidine (AZA) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) and in Newly Diagnosed (≥65 Years) AML Patients. Blood. 134(Supplement_1). 832–832. 57 indexed citations

12.

Vasu, Sumithira, Nelli Bejanyan, Steven M. Devine, et al.. (2019). BMT CTN 1803: Haploidentical Natural Killer Cells (CSTD002) to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM). Blood. 134(Supplement_1). 1955–1955. 3 indexed citations

13.

Webster, Jonathan, Marlise R. Luskin, Gabrielle T. Prince, et al.. (2018). Blinatumomab in Combination with Immune Checkpoint Inhibitors of PD-1 and CTLA-4 in Adult Patients with Relapsed/Refractory (R/R) CD19 Positive B-Cell Acute Lymphoblastic Leukemia (ALL): Preliminary Results of a Phase I Study. Blood. 132(Supplement 1). 557–557. 36 indexed citations

14.

Zeidner, Joshua F., Benjamin G. Vincent, Anastasia Ivanova, et al.. (2017). Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML). Blood. 130. 1349–1349. 10 indexed citations

15.

Knaus, Hanna A., Christopher G. Kanakry, Leo Luznik, & Ivana Gojo. (2017). Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia. Current Drug Targets. 18(3). 315–331. 35 indexed citations

16.

Norsworthy, Kelly J., Leo Luznik, & Ivana Gojo. (2012). New Treatment Approaches in Acute Myeloid Leukemia: Review of Recent Clinical Studies. Reviews on Recent Clinical Trials. 7(3). 224–237. 5 indexed citations

17.

Srinivasan, Mathangi, Ryan T. Flynn, Andrew Price, et al.. (2011). Donor B-Cell Alloantibody Deposition and Germinal Center Formation Are Required for the Development of Murine Chronic Gvhd and Bronchiolitis Obliterans. Blood. 118(21). 307–307. 1 indexed citations

18.

Luznik, Leo & Ephraim J. Fuchs. (2010). High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation. Immunologic Research. 47(1-3). 65–77. 151 indexed citations

19.

Duraković, Nadira, Vedran Radojčić, Mario Škarica, et al.. (2007). Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse. Blood. 109(10). 4564–4574. 24 indexed citations

20.

Altarac, Silvio, Filip Čulo, & Leo Luznik. (1990). Reduction of B16 melanoma lung metastases in C57Bl/6 mice by a combination therapy with tumor necrosis factor and indomethacin. Periodicum Biologorum. 92(1). 145–146. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact